We are live on ! Find out more
BFS

Bradley Foster & Sargent Portfolio holdings

AUM $6.44B
1-Year Est. Return 25.27%
This Fund
S&P 500
This Quarter Est. Return
+1.3%
1 Year Est. Return
+25.27%
3 Year Est. Return
+77.25%
5 Year Est. Return
+101.72%
10 Year Est. Return
AUM
$4.26B
AUM Growth
-$20.1M
Cap. Flow
-$50.3M
Cap. Flow %
-1.18%
Top 10 Hldgs %
30.91%
Holding
425
New
29
Increased
142
Reduced
157
Closed
18

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$26.3M
2
NDSN icon
Nordson
NDSN
+$6.48M
3
AVGO icon
Broadcom
AVGO
+$6.19M
4
COP icon
ConocoPhillips
COP
+$5.55M
5
ISRG icon
Intuitive Surgical
ISRG
+$3.83M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$19.3M
2
DE icon
Deere & Co
DE
+$5.46M
3
MSFT icon
Microsoft
MSFT
+$5.11M
4
MRCY icon
Mercury Systems
MRCY
+$4.37M
5
BABA icon
Alibaba
BABA
+$3.21M

Sector Composition

Rank Sector Weight
1 Technology 20.42%
2 Healthcare 17.37%
3 Financials 11.62%
4 Industrials 9.59%
5 Communication Services 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PGR icon
351
Progressive
PGR
$124B
$336K 0.01%
3,720
-996
-21% -$94.9K
BIP icon
352
Brookfield Infrastructure Partners
BIP
$17.5B
$327K 0.01%
8,736
K
353
DELISTED
Kellanova
K
$327K 0.01%
5,446
-1,917
-26% -$115K
XLY icon
354
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.8B
$327K 0.01%
+3,644
New +$331K
VRT icon
355
Vertiv
VRT
$104B
$325K 0.01%
13,500
EW icon
356
Edwards Lifesciences
EW
$53B
$321K 0.01%
2,835
-1,800
-39% -$205K
IUSG icon
357
iShares Core S&P US Growth ETF
IUSG
$33.8B
$321K 0.01%
+3,132
New +$331K
IGV icon
358
iShares Expanded Tech-Software Sector ETF
IGV
$15.1B
$319K 0.01%
4,000
STWD icon
359
Starwood Property Trust
STWD
$6.16B
$318K 0.01%
13,008
+508
+4% +$13K
DOCU
360
DocuSign
DOCU
$11.4B
$315K 0.01%
1,225
-70
-5% -$20.2K
MCO icon
361
Moody's
MCO
$82.8B
$312K 0.01%
+879
New +$331K
PNR icon
362
Pentair
PNR
$10.7B
$308K 0.01%
4,244
+4
+0.1% +$298
AZN icon
363
AstraZeneca
AZN
$251B
$293K 0.01%
+2,439
New +$284K
WRB icon
364
W.R. Berkley
WRB
$26.3B
$292K 0.01%
8,964
-42,975
-83% -$1.42M
CRSP icon
365
CRISPR Therapeutics
CRSP
$5.17B
$290K 0.01%
2,591
+10
+0.4% +$1.26K
RSG icon
366
Republic Services
RSG
$65.7B
$290K 0.01%
2,411
EXR icon
367
Extra Space Storage
EXR
$31B
$285K 0.01%
+1,696
New +$300K
RPM icon
368
RPM International
RPM
$14.8B
$283K 0.01%
3,650
CTSO icon
369
Cytosorbents Corp
CTSO
$22.7M
$278K 0.01%
34,240
-6,500
-16% -$52.8K
FATE icon
370
Fate Therapeutics
FATE
$322M
$276K 0.01%
4,657
CMS icon
371
CMS Energy
CMS
$21.7B
$266K 0.01%
4,459
-1,241
-22% -$77.4K
WBS icon
372
Webster Financial
WBS
$12.8B
$265K 0.01%
4,867
OGN icon
373
Organon & Co
OGN
$3.58B
$264K 0.01%
8,063
-6,383
-44% -$204K
PVG
374
DELISTED
PRETIUM RESOURCES INC.
PVG
$256K 0.01%
26,514
DGX icon
375
Quest Diagnostics
DGX
$26.2B
$254K 0.01%
1,750
+2
+0.1% +$293

Similar funds

Bradley Foster & Sargent's Q3 2021 Portfolio in Review

As of Q3 2021, Bradley Foster & Sargent held 425 positions worth $4.26B, down 0.47% from $4.28B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bradley Foster & Sargent's Q3 2021 filing shows 29 new, 142 increased, 157 reduced and 18 closed positions. Its largest new stake was Broadcom: 127,340 shares worth $6.17M. The largest sale was Vertex Pharmaceuticals, an estimated $19.3M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • Bradley Foster & Sargent's largest Q3 2021 buy was Broadcom: 127,340 shares worth $6.17M.
  • Bradley Foster & Sargent added most to Oracle in Q3 2021, an estimated $26.3M increase.
  • Bradley Foster & Sargent's biggest Q3 2021 reduction was Vertex Pharmaceuticals, cutting an estimated $19.3M.
  • Bradley Foster & Sargent fully exited Mercury Systems in Q3 2021, selling an estimated $4.37M.
  • Bradley Foster & Sargent's ten largest holdings make up 31% of its $4.26B portfolio in Q3 2021.
  • Bradley Foster & Sargent opened 29 new positions and closed 18 in Q3 2021.
  • Bradley Foster & Sargent's portfolio value fell 0.47% quarter-over-quarter to $4.26B.

Based on Bradley Foster & Sargent's 13F filing for Q3 2021, filed 10 Nov 2021.